Avid Bioservices (Avid Bioservices) Earnings per Share (Diluted)

: $-0.18 (TTM As of Oct. 2023)

View and export this data going back to 1996. Start your Free Trial

Avid Bioservices's Earnings per Share (Diluted) for the three months ended in Oct. 2023 was $-0.15. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2023 was $-0.18.

Avid Bioservices's EPS (Basic) for the three months ended in Oct. 2023 was $-0.15. Its EPS (Basic) for the trailing twelve months (TTM) ended in Oct. 2023 was $-0.18.

Avid Bioservices's EPS without NRI for the three months ended in Oct. 2023 was $-0.15. Its EPS without NRI for the trailing twelve months (TTM) ended in Oct. 2023 was $-0.18.

During the past 12 months, Avid Bioservices's average EPS without NRIGrowth Rate was -110.40% per year.

During the past 13 years, Avid Bioservices's highest 3-Year average EPS without NRI Growth Rate was 73.70% per year. The lowest was -78.30% per year. And the median was 13.00% per year.

Avid Bioservices Earnings per Share (Diluted) Historical Data

The historical data trend for Avid Bioservices's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avid Bioservices Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Earnings per Share (Diluted)

Get a 7-Day Free Trial

-0.16

-0.27

0.06

1.84

0.01

Avid Bioservices Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
Earnings per Share (Diluted)	Get a 7-Day Free Trial															-0.02	0.01	-0.01	-0.03	-0.15

Competitive Comparison

For the Biotechnology subindustry, Avid Bioservices's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avid Bioservices PE Ratio Distribution

For the Biotechnology industry and Healthcare sector, Avid Bioservices's PE Ratio distribution charts can be found below:

* The bar in red indicates where Avid Bioservices's PE Ratio falls into.

Avid Bioservices Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Avid Bioservices's Earnings Per Share (Diluted) for the fiscal year that ended in Apr. 2023 is calculated as

Diluted Earnings Per Share (A: Apr. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(0.56	-	0)	/	63.782
	=	0.01

Avid Bioservices's Earnings Per Share (Diluted) for the quarter that ended in Oct. 2023 is calculated as

Diluted Earnings Per Share (Q: Oct. 2023 )	=	(Net Income	-	Preferred Dividends	/	Shares Outstanding (Diluted Average)
	=	(-9.509	-	0)	/	63.149
	=	-0.15

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.18

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

Avid Bioservices (NAS:CDMO) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Avid Bioservices Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Avid Bioservices's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Avid Bioservices (Avid Bioservices) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avid Bioservices Inc (NAS:CDMO) » Definitions » Earnings per Share (Diluted)

Comparable Companies

Traded in Other Exchanges

TEHN:Germany

Address

14191 Myford Road, Tustin, CA, USA, 92780

Website

https://www.avidbio.com

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.

Executives

Matthew R. Kwietniak	officer: Chief Commercial Officer	14191 MYFORD ROAD, TUSTIN CA 92780
Richard A. Richieri	officer: Chief Operations Officer	14191 MYFORD ROAD, TUSTIN CA 92780
Daniel Ryan Hart	officer: Chief Financial Officer	2642 MICHELLE DR., SUITE 200, TUSTIN CA 62780
Mark R Ziebell	officer: V.P., General Counsel	14282 FRANKLIN AVENUE, TUSTIN CA 92780
Richard B Hancock	director	14282 FRANKLIN AVE., TUSTIN CA 92780
Joseph Carleone	director	3883 HOWARD HUGHES PKWY, SUITE 700, LAS VEGAS NV 89169
Nicholas Stewart Green	director, officer: President & CEO	2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780
Gregory Sargen	director
Esther M. Alegria	director	2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780
Mark R Bamforth	director	500 KENDALL ST., CAMBRIDGE MA 02142
Jeanne Thoma	director	C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE MN 56623
Patrick D Walsh	director	14282 FRANKLIN AVE., TUSTIN CA 92780
Catherine J Mackey	director	3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121
Joel Mccomb	director	9885 TOWNE CENTRE DRIVE, SAN DIEGO CA 92121
Stephen Michael Hedberg	officer: Principal Fin. & Acct. Officer	2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780